Related Experiment Video

Updated: Apr 4, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.7K

ANGPTL3 gene editing with CRISPR-Cas9: early trial insights

Xuan L Tang1, Amanda J Hooper1,2, John R Burnett2

  • 1Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth, Western Australia.

Expert Opinion on Investigational Drugs
|April 3, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ANGPTL3 inhibitorAngiopoietin-like 3CRISPR-Cas9CX310LDL-cholesterolapolipoprotein Bgene editingmonoclonal antibodysmall interfering RNAtriglyceride

More Related Videos

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

801
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
08:20

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9

Published on: November 3, 2020

7.1K

Related Experiment Videos

Last Updated: Apr 4, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.7K
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

801
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
08:20

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9

Published on: November 3, 2020

7.1K

Related Concept Videos

CRISPR01:59

CRISPR

59.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
59.2K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

2.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.7K

Articles linked to this work by shared authors, journal, and citation graph.

Birth prevalence and characterisation of congenital hyperinsulinism in Western Australia over two decades.

Journal of pediatric endocrinology & metabolism : JPEM·2026

Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory.

Pathology·2026

Assessing the clinical development of zerlasiran, a small-interfering RNA for elevated lipoprotein(a).

Expert opinion on investigational drugs·2025

Enhancing the detection of familial hypercholesterolaemia in general practice: A model for supporting genetic cascade testing in the community.

European journal of human genetics : EJHG·2025

Assessing the clinical progress of muvalaplin for reducing lipoprotein(a).

Expert opinion on investigational drugs·2025

PUTRA-CV study protocol: a multicentre observational study of ethnic-specific genetic variants and dietary patterns in relation to lipoprotein(a) levels and their association with coronary artery disease severity in Malaysian adults.

BMJ open·2025

Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.

Expert opinion on investigational drugs·2026

Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.

Expert opinion on investigational drugs·2026

Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.

Expert opinion on investigational drugs·2026

Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.

Expert opinion on investigational drugs·2026

Budigalimab: a viable option for patients with advanced solid tumors.

Expert opinion on investigational drugs·2026

Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.

Expert opinion on investigational drugs·2026

Unlocking G4 DNA affinity through aromatic side chains: a comparative study of nickel(II), copper(II), and zinc(II) salnaphen derivatives.

Dalton transactions (Cambridge, England : 2003)·2026

Impact of adsorption-based solidification on the pharmaceutical performance and antidyslipidemic efficacy of simvastatin-ezetimibe SNEDDS.

International journal of pharmaceutics: X·2026

Amphipathic β‑Sheet-Forming Octapeptide Self-Assembly Using the Martini Potential Family.

ACS omega·2026

Mol-CADiff: text-conditional molecule generation via causality-aware autoregressive diffusion.

Nature communications·2026

Integrated experimental and theoretical investigation of Cu(II), Mn(II), and Sr(II) chelates of an indole-based hydrazide derivative: synthesis, structural characterization, molecular docking, DFT studies, and biological evaluation.

Methods (San Diego, Calif.)·2026

Mechanistic evaluation of sulfobutylether-β-cyclodextrin complexation as a formulation strategy to enhance solubility and oral exposure of BCS Class II compounds.

International journal of pharmaceutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us